ID

13812

Description

A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01440920

Link

https://clinicaltrials.gov/show/NCT01440920

Keywords

Versions (2)
  1. 3/7/16 3/7/16 -
  2. 3/7/16 3/7/16 -
Uploaded on

March 7, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Acute Myeloid Leukemia NCT01440920

English

Eligibility Acute Myeloid Leukemia NCT01440920

1 forms  
Criteria
Description

Criteria

Alias
UMLS CUI-1
C1512693
patients with acute myeloid leukemia including patients with secondary leukemia. however, the patients with mds apparently evolved itno aml and patients with aml accompanied by t(15;17)(q22;q12),(pml/raralpha) , should be excluded.
Description

AML

Data type

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C2825139
UMLS CUI [3]
C0280449
patients who achieved the first complete remission after the induction regimen and finished a standard consolidation therapy.
Description

complete remission after induction regmin and standard consolidation

Data type

boolean

Alias
UMLS CUI [1]
C0677874
UMLS CUI [2]
C0392920
age: ≥ 60years of age(at the time of signature of the informed consent form)
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
sex: male and female
Description

gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
patients who are capable of giving informed consent
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
patient's blasts cells show expression of wt1mrna, detected by quantitative rt-pcr.
Description

WT1

Data type

boolean

Alias
UMLS CUI [1]
C0694898
UMLS CUI [2]
C0368761
patients must be one of the following hla drb1 types: hla-drb1*01:01, *04:05, *15:01, *15:02, *08:03 and *09:01.
Description

HLA drb1

Data type

boolean

Alias
UMLS CUI [1]
C0122040
Exclusion criteria
Description

Exclusion criteria

Alias
UMLS CUI-1
C0680251
patients who are scheduled for a bone marrow transplantation
Description

bone marrow transplantation

Data type

boolean

Alias
UMLS CUI [1,1]
C0005961
UMLS CUI [1,2]
C1301732
patients who were administered exceeded acceptable therapeutic dose of immunosuppressants and adrenal cortical steroids.
Description

immunosuppressant and steroids

Data type

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0038317
patients with uncontrollable active infectious diseases
Description

infection

Data type

boolean

Alias
UMLS CUI [1]
C0009450
patients with autoimmune diseases (including hashimoto's disease, idiopathic thrombocytopenic purpura, and autoimmune hepatitis) or with a medical history of active autoimmune diseases
Description

autoimmune diseases

Data type

boolean

Alias
UMLS CUI [1]
C0004364
immunocompetent patients
Description

immunocompetent patients

Data type

boolean

Alias
UMLS CUI [1]
C1512656
patients with a complication of interstitial pneumonia or with a medical history of interstitial pneumonia
Description

interstitial pneumonia

Data type

boolean

Alias
UMLS CUI [1]
C0206061
Back to the top of the page

Similar models

Eligibility Acute Myeloid Leukemia NCT01440920

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Criteria
C1512693 (UMLS CUI-1)
AML
Item
patients with acute myeloid leukemia including patients with secondary leukemia. however, the patients with mds apparently evolved itno aml and patients with aml accompanied by t(15;17)(q22;q12),(pml/raralpha) , should be excluded.
boolean
C0023467 (UMLS CUI [1])
C2825139 (UMLS CUI [2])
C0280449 (UMLS CUI [3])
complete remission after induction regmin and standard consolidation
Item
patients who achieved the first complete remission after the induction regimen and finished a standard consolidation therapy.
boolean
C0677874 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
age
Item
age: ≥ 60years of age(at the time of signature of the informed consent form)
boolean
C0001779 (UMLS CUI [1])
gender
Item
sex: male and female
boolean
C0079399 (UMLS CUI [1])
informed consent
Item
patients who are capable of giving informed consent
boolean
C0021430 (UMLS CUI [1])
WT1
Item
patient's blasts cells show expression of wt1mrna, detected by quantitative rt-pcr.
boolean
C0694898 (UMLS CUI [1])
C0368761 (UMLS CUI [2])
HLA drb1
Item
patients must be one of the following hla drb1 types: hla-drb1*01:01, *04:05, *15:01, *15:02, *08:03 and *09:01.
boolean
C0122040 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI-1)
bone marrow transplantation
Item
patients who are scheduled for a bone marrow transplantation
boolean
C0005961 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
immunosuppressant and steroids
Item
patients who were administered exceeded acceptable therapeutic dose of immunosuppressants and adrenal cortical steroids.
boolean
C0021081 (UMLS CUI [1])
C0038317 (UMLS CUI [2])
infection
Item
patients with uncontrollable active infectious diseases
boolean
C0009450 (UMLS CUI [1])
autoimmune diseases
Item
patients with autoimmune diseases (including hashimoto's disease, idiopathic thrombocytopenic purpura, and autoimmune hepatitis) or with a medical history of active autoimmune diseases
boolean
C0004364 (UMLS CUI [1])
immunocompetent patients
Item
immunocompetent patients
boolean
C1512656 (UMLS CUI [1])
interstitial pneumonia
Item
patients with a complication of interstitial pneumonia or with a medical history of interstitial pneumonia
boolean
C0206061 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial